Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan

MLA

Hara, Azusa, et al. “Comparison of the Incidence of Bleeding between Baloxavir Marboxil and Other Anti‐influenza Drugs among Outpatients with Influenza Virus Infection: A Retrospective Cohort Study Using an Employment‐based Health Insurance Claims Database in Japan.” Pharmacoepidemiology & Drug Safety, vol. 31, no. 6, June 2022, pp. 623–31. EBSCOhost, https://doi.org/10.1002/pds.5392.

APA

Hara, A., Hara, K., Komeda, T., Ogura, E., Miyazawa, S., Kobayashi, C., Fujiwara, M., Yoshida, M., & Urushihara, H. (2022). Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan. Pharmacoepidemiology & Drug Safety, 31(6), 623–631. https://doi.org/10.1002/pds.5392

Chicago

Hara, Azusa, Kanae Hara, Takuji Komeda, Eriko Ogura, Shogo Miyazawa, Chiduru Kobayashi, Masakazu Fujiwara, Manami Yoshida, and Hisashi Urushihara. 2022. “Comparison of the Incidence of Bleeding between Baloxavir Marboxil and Other Anti‐influenza Drugs among Outpatients with Influenza Virus Infection: A Retrospective Cohort Study Using an Employment‐based Health Insurance Claims Database in Japan.” Pharmacoepidemiology & Drug Safety 31 (6): 623–31. doi:10.1002/pds.5392.